Do or Die: Community Oncology Needs More Fellows medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Trial results from DESTINY-Breast06 indicate the effectiveness of fam-trastuzumab deruxtecan-nxki in delaying disease progression for patients with hormone receptor (HR)–positive and HER2-low metastatic breast cancer who had prior endocrine therapy.
Our top coverage from this year’s Community Oncology Conference, hosted by the Community Oncology Alliance, included discussions around alternative payment models, shifts in the community oncology landscape in recent decades, and the need for reform in several areas.
In a session held during the 2023 Patient-Centered Oncology Care® meeting, Erin Trish, PhD, co-director of the USC Schaeffer Center, fielded questions about the pharmacy benefit manager (PBM) landscape from Stephen Schleicher, MD, MBA, chief medical officer at Tennessee Oncology.